drugset / Trial / NCT00449111
An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Evaluate blood pressure after 6 weeks of treatment with COZAAR plus.
Timeline
- Start
- 2006-03-13
- Primary completion
- 2006-09-30
- Completion
- 2006-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Hydrochlorothiazide | Unknown | 25 mg | — |
| Subject | Losartan | Other / unclassified | 50 mg | — |
| Subject | Losartan | Other / unclassified | 100 mg | — |